Charles Haney, MD
Family Medicine · Pulaski, TNNPI 1285615385
Payments from drug & device makers
Across 127 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$296
- E.r. Squibb & Sons, L.L.C.$225
- Novo Nordisk$156
- AbbVie$152
- Pfizer$144
- Johnson & Johnson$133
- plus $981 from 24 others
What the payments were for
- Food & beverage$1,98695%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 19 | $296 |
| E.r. Squibb & Sons, L.L.C. | 22 | $225 |
| Novo Nordisk | 9 | $156 |
| AbbVie | 8 | $152 |
| Pfizer | 9 | $144 |
| Johnson & Johnson | 8 | $133 |
| Medtronic(2 entities) | 5 | $118 |
| Amarin Pharma, Inc. | 7 | $113 |
| Astellas Pharma US Inc | 1 | $99 |
| AstraZeneca | 5 | $82 |
| Amgen(2 entities) | 5 | $75 |
| Biohaven Pharmaceuticals, Inc. | 3 | $66 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| GSK | 3 | $46 |
| Dexcom, Inc. | 3 | $44 |
| Boehringer Ingelheim | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Abbott | 1 | $24 |
| Biogen | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Novartis | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Hologic Sales And Service, LLC | 1 | $12 |
How this compares
$2,085 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 41 | $532 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $471 |
| Pravastatin Sodium | 17 | $425 |
| Glimepiride | 16 | $366 |
| Atorvastatin Calcium | 33 | $330 |
| Levothyroxine Sodium | 39 | $285 |
| Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide | 13 | $212 |
| Amlodipine Besylate | 29 | $210 |
| Lisinopril | 28 | $202 |
| Allopurinol | 22 | $189 |
| Metformin Hcl ErMetformin Hcl | 13 | $136 |
| Omeprazole | 16 | $109 |
| Simvastatin | 18 | $104 |
| Losartan Potassium | 11 | $76 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Pulaski
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.